[Skip to content]

Cancer Advice - from leading UK Cancer Specialists
Find information
In this section...
On this site...
.

Risk reducing Salpingo-oophorectomy in women with the brca 1/2 mutation in their genome

Patients with the BRCA mutation in their genome are at a very high risk of developing breast or gynaecological cancer in their lifetime. Prophylactic mastectomies are considered in such patients, who have at least a 85% risk of cancer in the breast. In a careful study reported a this year's American Society of Clinical Oncology (ASCO) meeting, evidence was presented supporting the use of prophylactic salpingo-oophorectomy (the removal of ovaries and tubes as an insurance policy)in such women, to lower the subsequent risk of cancer (proc ASCO 2002 Abstract 3).